Background Previous studies have found rotavirus vaccination to be highly cost-effective in low-income countries. However, updated evidence is now available for several inputs (ie, rotavirus disease mortality rates, rotavirus age distributions, vaccine timeliness, and vaccine efficacy by duration of follow-up), new rotavirus vaccines have entered the market, vaccine prices have decreased, and cost-effectiveness thresholds have … Continued
Focus Area: Evaluating cost and cost-effectiveness of immunization programs
Results 1 -10 of 19
Rotavirus Vaccination is Cost Effective and Saves Lives, New Analysis Finds
In an analysis published in the December issue of The Lancet Global Health, investigators from PATH, the London School of Hygiene & Tropical Medicine, and the US Centers for Disease Control and Prevention, analyzed the potential costs of rotavirus vaccination for 10 successive birth cohorts (from 2018 through 2027) in 73 countries eligible for Gavi support, compared … Continued
WHO Guide for Standardization of Economic Evaluations of Immunization Programs
WHO has recently published a new edition of the guidance to meet the increased need to carry out immunization economic evaluations for decision making using the latest methodologies. This updated guide brings together the recommendations and guidance from many recent guidelines, tools and other documents on specific aspects of immunization and on specific vaccines. The … Continued
The Costs of Delivering Vaccines in Low- and Middle-income Countries: Findings from a Systematic Review
Abstract Information on immunization delivery costs (IDCs) is essential for better planning and budgeting for the sustainability and performance of national programs. However, delivery cost evidence is fragmented and of variable quality, making it difficult for policymakers, planners, and other stakeholders to understand and use. This study aimed to consolidate and summarize the evidence on … Continued
Updated Analyses on Immunization Delivery Costs now Available at immunizationeconomics.org/ICAN
In May 2018, ThinkWell released findings from a systematic review of the evidence base on immunization delivery costs (IDC) in low- and middle-income countries (LMICs). The review aimed to answer a question frequently asked by global and country immunization stakeholders: What are the unit costs of vaccine delivery across different LMICs and through a variety … Continued
Continuing Pneumococcal Vaccination After Gavi Transition in Kenya at Full Price is Cost-effective and Could Save Thousands of Lives
This news release was originally published on EurekAlert. Below is an excerpt from the news release. Co-led by the London School of Hygiene & Tropical Medicine and the KEMRI-Wellcome Trust Research Program, the Pneumococcal Conjugate Vaccine Impact Study estimated that continuing the vaccine beyond 2022 would prevent – in the first ten years – more than … Continued
Sustaining Pneumococcal Vaccination After Transitioning from Gavi Support: A Modelling and Cost-effectiveness Study in Kenya
Background In 2009, Gavi, the World Bank, and donors launched the pneumococcal Advance Market Commitment, which helped countries access more affordable pneumococcal vaccines. As many low-income countries begin to reach the threshold at which countries transition from Gavi support to self-financing (3-year average gross national income per capita of US$1580), they will need to consider … Continued
Training Video: Applied Health Economics in Africa – Using Examples from Immunization
Using examples from immunizations, this Teaching Vaccine Economics Everywhere (TVEE) training video focuses on developing skills in economic evaluations, carrying out a cost effectiveness and budget impact analysis, and building local capacity in vaccine economics. The training was conducted at a 2019 AfHEA pre-congress session. View the TVEE training video in full.
Pre-conference Workshop: Applied Health Economics in Africa: Using Examples from Immunization
03/11/2019
Accra, Ghana
The Teaching Vaccine Economics Everywhere (TVEE) project is offering a workshop on methods and processes for priority setting related to healthcare interventions, drawing on examples related to immunization as an entry point for capacity strengthening and skills building. This pre-conference workshop will be held from 8:30 AM to 4:30 PM on March 11, 2019 prior to … Continued
Expenditures on Vaccine-preventable Disease Surveillance: Analysis and Evaluation of Comprehensive Multi-year Plans (cMYPs) for Immunization
Despite the importance of vaccine-preventable disease (VPD) surveillance, little is known about the costs of monitoring disease. Researchers used Comprehensive Multi-Year Plans for Immunization (cMYPs) – developed by countries following guidelines from the World Health Organization and United Nations Children’s Fund – to estimate expenditures on VPD surveillance at the country level in 2015 US … Continued